Opportunity Overview
Asthma is the commonest childhood long-term inflammatory airways disease. Unpredictable asthma attacks cause sudden worsening of symptoms and may be fatal. Current routine treatment using inhaled corticosteroids and bronchodilators prevents asthma attacks in only 68 per cents of patients. We aim to achieve asthma control by developing an AI-based predictive model for asthma attacks using our unique longitudinal data collected in the paediatric difficult asthma clinic at the Royal Brompton hospital.
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Other NPIF |
|---|---|
| Country | United Kingdom |
| Category | Research Development |
| Published | September 30, 2024 |
| Procurement stage | Active solicitation |
| Closed | Closing date not published |
| Status | Closed — no longer accepting responses |
| Official source | View original notice |
| Last verified | October 10, 2026 |
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
Browse Similar Open Opportunities in United Kingdom
See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United Kingdom Research Development intelligence report in your inbox
A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.